6Lazzarin A,Capsoni F,Leurti M,et al.Immunological characteristics of preterm neonates after prophylaxis of NRDS.In:Bianali M,Cosmi EV,Luerti M,eds.Diagnosis and treatment of fetal lung immaturity.Milan:Masson,1986.134-139.
7Wauer RR,Schmalisch G,Hammer H,et al.Ambroxol for prevention and treatment of hyaline membrane disease.Eur Respir J,1989,3(Supple 3):57s-65s.
8Gibbs RS,Duff P.Progress in pathogenesis and management of clinical intraamniotic infection.Am J Obstet Gynecol,1991,164:1317-26.
9Vermillion ST,Soper DE,Bland ML,et al.Effectiveness of antenatal corticosteroid administration after preterm premature rupture of the membranes.Am J Obstet Gynecol,2000,183:925-929.
10Luerti M,Lazzarin A,Corbella E,et al.An alternative to steroids for prevention of respiratory distress symdrome (RDS):multicenter controlled study to compare ambroxol and betamethasone.J Perinat Med,1987,15:227-238.
